Research, About Georgia Pollens, LLC/ Dennis Robinson, MD
Our
research facility is run by Jonnie Owens,RN and Tracy Bridges, MD. Many
types of allergy and asthma related research by major pharmaceutical
sponsors are performed. You can learn more about this by contacting
Jonnie at jowens@aacoga.com or at 229-883-8909.
Currently Seeking Participants for Research Trials/ Jonnie Owens, Research Director
Research
trials are VOLUNTARY participation. Participants are compensated a
nominal amount for participation. This may include FREE medication,
FREE physician assessment and FREE study related procedures, such as
pulmonary funtion testing (PFT), skin testing, EKG and laboratory
evaluation. Trials currently seeking participants include
(1)AstraZeneca African American Asthma trial,(2)APPLES Atopic Dermatits
Trial,(3)PEER Atopic Dermatitis Trial,(4)Novartis Xolair ACT Trial.
Please contact Jonnie Owens at 229-883-8909 or jowens@aacoga.com if
intereste in any current or upcoming research trial.
SEE THE HEADING: ASTHMA RESEARCH FOR MORE DETAILS.
SEE THE HEADING: SKIN ALLERGY RESEARCH FOR MORE DETAILS.
Asthma Research
AstraZeneca African American Asthma Trial/ Jonnie Owens, Research Director
This
is a 12-week trial comparing the safety and efficacy of Symbicort twice
daily versus budesonide twice daily in adult and adolescent (> 12
years) African American subjects with asthma. Subjects are provided a
hand-held computer(log pad)to enter daily asthma information.
Participants are assessed every 2 weeks and compensated $40 each scheduled visit for time and transportation. If interested, contact Jonnie Owens at 229-883-8909.
Novartis Xolair ACT Trial/ Jonnie Owens, Research Director
A
28-week study for persons ages 12-75 years with uncontrolled moderate
to severe allergic asthma evaluating the effect of subcutaneous
Omalizumab (XOLAIR) on markers of airway impairment (ACT "Asthma
Control Test" questionnaire). Participants are assessed every 2-4 weeks
depending on the Omalizumab dosing schedule. Reimbursement of $32 at
each visit will be compensated for each participant's time and
transportation to study related visits. If interested, contact Jonnie
Owens at 229-883-8909 or jowens@aacoga.com.
HUGE global GSK asthma/COPD trial / Jonnie Owens, Research Director
COMING
SPING 2009...GSK will be performing a COPD and asthma trial. Appx. 7000
subjects will be participating at mutiple sites globally. More
information to follow...If interested, contact Jonnie Owens at Georgia
Pollens at 229-883-8909 or jowens@aacoga.com
Skin Allergy Research
APPLES Atopic Dermatits Trial/ Jonnie Owens, Research Director
(For
ages 7 to 17) The APPLES study is a phase IV, 5-year trial assessing
the long-term safety of Tacrolimus (Protopic) ointment for the
treatment of Atopic Dermatitis. Participants are seen every 6 months at
NO CHARGE and a $10 gift card is given for each set of phone questions
that are completed and returned to the sponsor. If interested, please
contact Jonnie Owens at 229-883-8909 or jowens@aacoga.com.
PEER Atopic Dermatitis Trial/ Jonnie Owens, Research Director
The
PEER program is an observational trial for children with eczema (also
known as atopic dermatitis) and who is using or has previously used
Elidel cream for the treatment of eczema. Participants must have used
Elidel for at least 42 days within the 6 month period prior to
enrollment to be eligible. Follow up surveys are completed every 6
months for 10 years and participants are compensated $25 within 2-4
weeks of completing/returning each survey. If interested, contact
Jonnie Owens at 229-883-8909 or jowens@aacoga.com.
